LDI Research Seminar with Jennifer Haas, MD, MSHP
“Targeted testing and treatment for breast cancer: implications for disparities”
Jennifer S. Haas MD, MSPH is an Associate Professor of Medicine in the Division of General Medicine at Brigham and Women’s Hospital and Harvard Medical School, and in the Department of Society, Human Development, and Health at the Harvard School of Public Health. She is a practicing general internist with a master’s degree in health policy from the Harvard School of Public Health. Dr. Haas is the Co‐ Director of the Harvard Catalyst (CTSC) Health Disparities Research Program. She received a BS from Yale University in Molecular Biophysics and Biochemistry and Chinese Studies, an MD from Harvard Medical School, and a Masters of Science from the Harvard School of Public Health. She completed a residence in primary care internal medicine at the University of California, San Francisco and fellowship training in general internal medicine at Brigham and Women’s Hospital.
Dr. Haas’ research has focused on elucidating and eliminating disparities in health care and health status by insurance status, socioeconomic status, and race/ ethnicity. Her recent work has focused on disparities in cancer control and outcomes, and the impact of policies related to prescription drugs on disparities. She is particularly interested in how the social environment or health care market may influence disparities in the dissemination of information, treatments, and survival. She is currently interested in examining how the development of personalized tests and treatments for cancer (i.e., genomically targeted) may influence disparities. She is also interested in the use of health information technology to improve communication of health‐related information. Dr. Haas has published over 100 peer‐reviewed articles, and has been continuously funded as a Principal Investigator for over 15 years. She is a Fellow of the American College of Physicians.
This event is free and open to the public, but registration is required.
Sponsored by the Charles C. Leighton, MD Memorial Lecture Fund